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High risk Neuroblastoma (NB) includes aggressive, metastatic solid tumors of
childhood. The survival rate improved only modestly, despite the use of combination
therapies including novel immunotherapies based on the antibody-mediated targeting of
tumor-associated surface ligands. Treatment failures may be due to the lack of adequate
in vitro models for studying, in a given patient, the efficacy of potential therapeutics,
including those aimed to enhance anti-tumor immune responses. We here propose a
3D alginate-based hydrogel as extracellular microenvironment to evaluate the effects
of the three-dimensionality on biological and immunological properties of NB cells. NB
cell lines grown within the 3D alginate spheres presented spheroid morphology, optimal
survival, and proliferation capabilities, and a reduced sensitivity to the cytotoxic effect
of imatinib mesylate. 3D cultured NB cells were also evaluated for the constitutive and
IFN-γ-induced expression of surface molecules capable of tuning the anti-tumor activity
of NK cells including immune checkpoint ligands. In particular, IFN-γ induced de novo
expression of high amounts of HLA-I molecules, which protected NB cells from the
attack mediated by KIR/KIR-L matched NK cells. Moreover, in the 3D alginate spheres,
the cytokine increased the expression of the immune checkpoint ligands PD-Ls and
B7-H3 while virtually abrogating that of PVR, a ligand of DNAM-1 activating receptor,
whose expression correlates with high susceptibility to NK-mediated killing. Our 3D
model highlighted molecular features that more closely resemble the immunophenotypic
variants occurring in vivo and not fully appreciated in classical 2D culture conditions.
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Thus, based on our results, 3D alginate-based hydrogels might represent a
clinical-relevant cell culture platform where to test the efficacy of personalized therapeutic
approaches aimed to optimize the current and innovative immune based therapies in a
very systematic and reliable way.
Keywords: 3D cancer model, neuroblastoma, NK cells, PVR, KIRS/HLA-I, PD-Ls, B7-H3 and IFN-γ, immunotherapy
INTRODUCTION
Neuroblastoma (NB) is a pediatric cancer accounting for 6%
of all children malignancies (1, 2). It represents a worldwide
emergency since it is responsible for up to 10% of mortality
in childhood cancer. In particular, high-risk NBs are extremely
aggressive as they present resistance to therapy and relapses,
mainly due to recurrence of bone marrow metastasis. Thus,
an unmet therapeutic need exists that prompts the scientific
community to identify innovative therapeutic strategies, which
may include immunotherapies based on the enhancement of
Natural Killer (NK) lymphocytes activity.
NK cells are the cytolytic members of the Innate Lymphoid
Cells family (ILC) (3, 4). The capability of NK cells to attack
abnormal targets such as tumors, while sparing healthy cells,
depends on a balance between inhibitory and activating signals.
The strongest inhibitory signals are mediated by the heterodimer
CD94/NKG2A and by Killer Ig-like receptors (KIRs), clonally
distributed surface receptors interacting with specific HLA class
I (HLA-I) allotypes, referred as KIR-ligands (KIR-L). These
inhibitory receptors tune the effector functions of NK cells
and regulate their cross-talk with other immune cells such as
Dendritic Cells (5) or Macrophages (6), a process that lead to
the amplification of innate and adaptive immune responses.
Moreover, during NK cell maturation, the engagement of
HLA-I-specific receptors is required for NK cell “licensing,” a
complex educational program that allow NK cells to acquire
a fully functional phenotype getting the “license to kill” (7).
Indeed, mature “licensed” NK cells are characterized by high
cytolytic potential and by the expression of a plethora of
functional activating receptors and co-receptors. These include
NKp46 (8), NKp30 (9), NKp44 (10) (collectively named Natural
Cytotoxicity Receptors, NCRs), NKG2D (11), and DNAM-1 (12)
that, interacting with specific ligands on tumor targets, stimulate
NK cells killing, and cytokines release (13). In particular, the
interaction of DNAM-1 with its ligand PVR (polio virus receptor,
CD155) (14) plays a pivotal role in cell-to-cell adhesion (15) and
in immune synapses formation. It has been shown to be crucial
for killing of ex-vivo derived tumors including NB that do not
express HLA-I molecules at the cell surface (16–21).
The expression of HLA-I surface molecule in tumor
cells can impair the NK cell-mediated attack through the
engagement of the specific inhibitory receptors. Moreover,
tumors can evade immune responses via the exploitation of the
“immune checkpoints,” inhibitory pathways that physiologically
maintain self-tolerance and limit the duration and amplitude
of immune responses. These include the PD-L1 and PD-L2
ligands recognized by the Programmed cell death 1 (PD-1)
receptor (22–24), and the B7-H3 orphan ligand interacting
with a still unknown receptor (25, 26). PD-Ls and B7-H3 are
expressed/upregulated by tumors and act as shields protecting
cancer cells from the NK (and T) cells attack (27, 28). Notably,
IFN-γ, which is released by NK (and Th1) cells during immune
responses, is able to increase the expression of HLA-I, and PD-L1
molecules in different tumor cells including NB (23, 29–31).
Novel therapeutic approaches in high-risk NB patients
consider the enhancement of immune responses through the
disruption of the PD-1/PD-Ls and/or B7-H3R/B7-H3 axes (27,
28). An additional possibility is targeting B7-H3, which can be
achieved by using antibodies (32) or B7-H3-CAR engineered T
(33, 34) or NK cells (27). In this context, B7-H3 has not been
detected in most normal tissues including the nervous system
(35, 36).
Based on experimental evidences obtained from in vitro and
mice animal models, combined therapies have been designed;
however, the patients’ survival rate was poorly improved. Clinical
failure may be due to several reasons including the inadequacy
of the simplistic pre-clinical in vitro and in vivo animal tumor
models. Conventional 2D cultures do not allow the persistence
of NB cells isolated from patients, hampering the evaluation
of the responses to therapy in a single patient, as required
by personalized medicine that takes into account the great
individual biological variability.
Therefore, there is an exigency to develop novel in vitro
3D models characterized by more reliable dimensional context
and higher degree of physiological relevance and suitable for
approaching personalized immunotherapies. To meet this need,
bioengineering of the tumor microenvironment is beneficial,
and biomaterials play a role in this endeavor. Among these,
bioengineered 3D hydrogels can provide a link between in
vitro and in vivo systems, since they well resemble the special
characteristics of the tumor microenvironment, including
tunable stiffness and ductility modulations, programmed
degradability, cancer-specific biomarker responsibility, and
other properties (37, 38).
Among them, seaweed-derived alginate is an inert polymer,
lacking the native bonds, which are usually responsible
of the interactions with mammalian cells, differently from
natural polymers like collagen or laminin (39–41). For this
reason, alginate-based materials allow to better isolate and
distinguish the contribution of the physico-structural properties
of the substrates on cell fate, respect to chemically bioactive
materials (42, 43).
The architecture, stiffness, and composition of the
extracellular matrix (ECM) could in fact affect cell migration,
invasion, and proliferation in human cancers as well as the
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cellular immune-phenotype and the sensitivity to anticancer
drugs and immunotherapeutic approaches. Therefore, we here
developed and validated a biomimetic culture platform based
on cell-laden alginate-based spheroids as promising and reliable
NB 3D tumor model. In particular, a characterization of cell
viability, proliferation, drug sensitivity and ligand repertoire
has been carried out, by using two prototypic human NB cell
lines. Compared with conventional 2D cell monolayer cultures,
NB cells grown within the 3D alginate hydrogels present
a spheroid morphology, resembling in vivo organization, a
decreased sensitivity to the cytotoxic effect of imatinib mesylate
and revealed an interestingly and previously unappreciated,
constitutive and IFN-γ induced, immune-phenotype.
MATERIALS AND METHODS
NB Cell Lines and Cell Culture
The NB cell line HTLA-230 was provided by Dr. E. Bogenmann
(Children’s Hospital Los Angeles, Los Angeles, CA) (44);
the SH-SY5Y cell line was purchased from Banca Biologica
and Cell Factory (IRCCS Azienda Ospedaliera Universitaria
San Martino-IST, Genoa, Italy). NB cell lines were cultured
in the presence of complete medium composed of RPMI
1640 medium supplemented with 10% heat-inactivated FCS
(Biochrom, Berlin, Germany), 50 mg/ml streptomycin, 50 mg/ml
penicillin (Sigma-Aldrich), and 2mM glutamine (EuroClone),
either in the absence or in the presence of INF-γ (100 ng/ml).
NB cell lines were periodically checked for MYCN gene
amplification by fluorescence in situ hybridization analysis
and for morphology, proliferation rate, and mycoplasma
contamination, after thawing and within four passages in
culture. KIR-L were attributed analyzing the HLA-I typing,
using the website http://www.ebi.ac.uk/ipd/kir/ligand.html. Cells
were used to realize 3D tumor model (see below) and
conventional 2D cultures (10,000 cells/well in in 24-well flat-
bottom plates).
3D Tumor Model Formation and Culture
Alginate powder (Manugel GMB, FMC Biopolymer) was
dissolved in physiologic solution at the concentration of 1%
w/v and the solution was filtered through a 0.2mm membrane
under sterile conditions. HTLA-230 and SH-SY5Y were detached
from plastic tissue culture flasks by using phosphate-buffered
saline containing 5mM EDTA and resuspended at a density
of 4 × 106 cells/mL in DMEM supplemented with 10%
FBS and 1% penicillin/streptomycin. Afterward, the NB cells
suspension was mixed with the sterile alginate solution (1/1
V/V) to obtain a final Alg concentrations of 0.5% w/V and
a cellular density of 2 × 106 cells/mL. The NB cells/alginate
suspensions were dripped by 21-gauge needle into a 0.5M
CaCl2 gelling bath and kept for 10min at 37
◦C to form
alginate spheres. After washing the spheres with DI water
to remove the excess of Ca, the NB cell-laden alginate
spheres were cultured in 96 multi-wells up to 1 week in
DMEM supplemented with 10% FBS, 1% penicillin/streptomycin
and CaCl2 (5mM). They were incubated in a humidified
environment (5% CO2) at 37◦C and the medium was
changed after 3 days (Patent n◦ 102018000005459; Owner:
React4life S.r.l.).
Dimensional Characterization of the NB
Cell-Laden Alginate Spheres
Themorphology of NB cell-laden alginate spheres wasmonitored
up to 1 week of culture. After 1, 3 and 7 days of culture
NB-alginate spheres were fixed in 4% paraformaldehyde and
stained with DAPI fluorescent nuclear dye to observe NB
cells nuclei. Imaging was performed with a fluorescence
microscope (Nikon H550L). Images obtained by fluorescence
microscopy were analyzed through Image J software, in order
to quantify the eventual temporal change of the morphological
features of NB cell-laden alginate spheres. In particular, the
following morphological parameters were measured: diameter;
area; circularity, defined as 4π Area/ Perimeter2; and axis ratio,
defined as Major Axis/Minor axis.
Cellular Organization Within NB Cell-Laden
Alginate Spheres
After 1 week of culture, cell-laden NB alginate spheres
were processed for histological analysis. Samples were
fixed in 4% paraformaldehyde, then paraffin embedded and
sectioned (5 µm).
Deparaffinized and rehydrated paraffin sections were
routinely stained with hematoxylin and eosin (H&E) and
observed under optical microscope (Nikon h550L).
Other hydrated sections were processed for AFM analysis. In
particular, re-hydrated samples were let dry in laminar flow box
and analyzed by AFM (Nanowizard3, JPK, Berlin, Germany).
Due to the adhesiveness of the sample, topography imaging
of the embedded cells and surrounding gel were reconstructed
using the point of contact of high-resolution (128∗128 points)
force-distance maps performed in air. A soft cantilever NITRA-
TALL B (AppNano, Mountain View, CA, USA), with nominal
spring constant 0.1N/m, was calibrated calculating the deflection
sensitivity against a freshly peeled mica sheet and subsequently
using the thermal noise method. Obtained images were post-
processed in Gwyddion 2.50.
NB Cell-Laden Alginate Spheres Viability,
Proliferation, and Drug Sensitivity
NB cells viability within alginate-based tumor models was
evaluated through a live/dead assay (Sigma Aldrich). Briefly, after
24 h NB cell-laden alginate spheres were washed with PBS and
incubated in 2mM calcein AM and in 4mM EthD-1 in PBS for
15min at 37◦C in a dark environment, to detect live and dead
cells, respectively. NB cell-laden alginate spheres were washed
three times in PBS. Positivity to either staining solution was
observed by means of fluorescence microscopy (Nikon H550L).
NB cells proliferation within tumor models was quantitatively
assessed through Presto Blue Assay (Thermo Fisher Scientific).
NB cells cultured over 24 wells were used as control. In brief, after
1 day (DAY 1), 3 days (DAY 3), and 7 days (DAY 7) of culture the
medium was removed from all samples and replaced with fresh
medium containing 1% v/v of Presto Blue solution, as indicated
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by the manufacturer. Samples were incubated at 37◦C for 1.5 h in
dark. The supernatants were collected and absorbance readings
at 570 and 600 nm assessed spectrophotometrically.
For the analysis of drug sensitivity, HTLA-230 cell-
laden alginate spheres were treated for 24 h with decreasing
concentration of clinical-grade imatinib mesylate (Selleck
Chemicals, USA). Drug cytotoxicity on NB cell lines was
quantitatively assessed through Presto Blue Assay. Briefly,
the medium was removed from samples and replaced with
fresh medium containing 1% v/v of Presto Blue solution,
and incubated at 37◦C for 1.5 h in dark. The supernatants
were collected and absorbance readings at 570 and 600 nm
assessed spectrophotometrically. 3D results were compared with
conventional 2D cultures.
Immunostaining
NB-alginate spheres were cultured with and without INF-
γ (PeproTech, Rock Hill, NJ) at the final concentration of
100 ng/ml. After 7 days, samples were washed three times with
PBS and incubated with the appropriate primary mAb for 1 h
at room temperature. After washing three times in PBS, samples
were incubated for 1 h at room temperature with Phycoerythrin
(PE)-conjugated isotype-specific goat anti-mouse second reagent
(Southern Biotechnology Associated, Birmingham, AL). Imaging
was performed with a fluorescence microscope (Nikon H550L).
Quantification of fluorescence was carried out through Image J R©
software from fluorescent images. In particular, measurements
of the positive stained area were assessed through a semi-
automatic image post-processing of the binarized images. All the
measurements were carried out in quintuplicate for each category
of samples.
Monoclonal Antibodies
The following primary mAbs were produced in our laboratories:
M5A10 (IgG1, anti-PVR), L14 (IgG2a, anti-nectin-2), BAM195
(IgG1, anti-MICA), A6136 (IgM, anti-HLA class-I), NE97
(IgG2b, anti-B7-H3) (25), BAB281 (IgG1, anti-NKp46) (8). Anti-
PD-L1.3.1 (IgG1, anti-PD-L1), and anti-PD-L2 (IgG1) were
produced in D. Olive lab. D1.12 (IgG2a anti-HLA-II) mAb was
produced by R. Accolla (University of Insubria, Varese, Italy).
Anti-ULBP1-4 were purchased from R&D System (Minneapolis,
US) and Santa Cruz Biotecnology (Dallas, US); anti-GD2 (IgG2a)
was purchased from BD Bioscience PharMingen, San Diego,
CA); anti-CXCR4 (IgG2b) was purchased from &D Systems
(Minneapolis, MN).
The following fluorochrome-conjugated anti-KIR in
combination with anti-CD3-PECF594 (IgG1; BD Bioscience)
and anti-CD56-PC7 (IgG1; Beckman Coulter, Marseille, France)
mAbs were used: GL-183 (IgG1, anti-KIR2DL2/L3/S2; Beckman
Coulter), EB6B (IgG1, anti-KIR2DL1/S1 and KIR2DL3∗005;
Beckman Coulter), Z27 (IgG1, anti-KIR3DL1/S1; Beckman
Coulter), DX9 (IgG1, anti KIR3DL1; Miltenyi Biotec, Bergisch
Gladbach, Germany), FES172 (IgG2a, KIR2DS4; Beckman
Coulter), 143211 (IgG1, anti-KIR2DL1 and KIR2DS5; R&D).
ECM41 mAb (IgM, anti-KIR2DL3, with the exception of ∗005;
Our laboratory) followed by FITC-conjugated goat anti-mouse
IgM (Southern Biotech, Birmingham, AL) was also used.
Immunofluorescence and Flow Cytometry
NB cells were detached by the use of the chelating agent
EDTA (2D cultures) or recovered from 3D alginate hydrogels
as described below. Cells were stained with the primary mAbs
followed by Phycoerythrin (PE)-conjugated isotype-specific
goat anti-mouse second reagents (Southern Biotechnology
Associated, Birmingham, AL), and analyzed by flow cytometry
(FACSCalibur Becton Dickinson & Co, Mountain View, CA).
On every experimental session, the flow cytometer performances
were monitored, the reproducibility of the fluorescence intensity
was aligned by calibrated microsfere (Becton Dickinson & Co,
Mountain View, CA) and isotype-matched irrelevant antibodies
were used as controls.
Peripheral blood mononuclear cells (PBMC) were isolated by
Ficoll-Hypaque density gradient from blood of healthy donors,
upon informed consent, and frozen at −80◦C. KIR surface
expression by NK cells was analyzed on freshly derived or thawed
PBMC by immunofluorescence. Appropriate combinations of
fluorochrome-conjugated anti-KIR mAb were used to identify
inhibitory and activating KIR. Cytofluorimetric analysis was
performed by MACSQuant-analyzer (Miltenyi-Biotec, Bergisch
Gladbach, Germany). Data were analyzed using FlowJo Version
10 (TreeStar).
Recovery of NB From Alginate Hydrogels
and CD107a Degranulation Assay
NB cell-laden hydrogels were treated with alginate solubilizing
solution (0.15M NaCl and 55mM Sodium Citrate, Sigma
Aldrich) in a volume of 100 µl/hydrogel, incubated at 37◦C
until alginate fully dissolves (about 20min), washed twice
with complete medium and pelleted by centrifugation (1400
rpm/7 min).
In degranulation assays PBMC from KIR2DL1pos,
KIR2DL2/S2neg, KIR2DL3pos, KIR3DL1pos HLA-C1/C2 donors
were used as effectors and HTLA-230 (KIR-L: HLA-A3, HLA-
Bw4, HLA-C1/C1) recovered from alginate hydrogels as targets.
PBMC were thawed, cultured for 3 days in the presence of IL-2
(600 IU/ml) to stimulate NK cell populations, incubated for 3 h
with target cells in the presence of a PE-conjugated anti-human
CD107a (LAMP-1) (IgG1; BD Biosciences) and analyzed by
flow cytometry.
RNA Extraction and Real Time PCR
NB cells were recovered from the alginate hydrogels as above
described and total RNA was extracted by using the miRCURY
RNA Isolation Kit—Cell and Plant (Exiqon). 250 ng of RNA
were reverse transcribed using the SuperScript VILO cDNA
Synthesis Kit (Invitrogen). The cDNA was amplified by real-
time PCR using specific TaqMan Gene Expression Assays
(Applied Biosystems). Expression of B7-H3, PD-L1, PD-L2, and
PVR genes was normalized to the GAPDH gene expression.
Experiments were performed in triplicate.
Statistical Analysis
For the quantitative evaluation of the morphological parameters
of NB cell-laden alginate spheres over time and proliferation
rate, data were analyzed by Student’s paired t-test and statistical
significance was set at p < 0.05, n= 5.
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Student’s paired t-test was performed for drug sensitivity
analysis and statistical significance was set at p < 0.05, n= 4.
For the quantitative analysis of the fluorescent images,
measurements were analyzed by Student’s paired t-test and the
statistical significance (p) is indicated, n= 5.
Wilcoxon-Mann-Whiteny p-value test or Student’s t-test were
employed for cytofluorimetric analysis and real time PCR,
respectively. The statistical significance (p) is indicated. Graphic
representation and statistical analysis were performed using the
PASW Statistic version 20.0 software (formerly SPSS Statistics)
(IBM, Milan Italy) and GraphPad Prism 6 (GraphPad Software
La Jolla, CA).
RESULTS
NB Cell-Laden Hydrogel Tumor Model
We selected two prototypic NB cell lines, HTLA-230
characterized by MYCN amplification and 1p deletion, and
SH-SY5Y that lacks MYCN amplification and 1p deletion
(31). NB cells were embedded into alginate spheres, cultured
for 1 week as described in materials and methods section,
and the morphological properties analyzed at different time
points (Figure 1).
NB cells grown within the 3D alginate spheres presented
a spheroid morphology, high nucleus/cytoplasm ratio and
clustered organization, resembling in vivo organization and
phenotype, as shown in the histological and Atomic Force
Microscopes (AFM) images (Figures 1A,B).
The NB cell-laden hydrogels had a spherical shape, which
remained quite constant up to the later stage of culture
(Figures 1B,C). Uniform and reproducible shape and size of in
vitro tumor models are crucial for their potential use as relevant
informative tools in therapies/drug testing (45). Therefore, a
quantitative analysis over time of NB cell-laden hydrogels in
terms of variations of diameter, area, circularity, and axis ratio
(representative of the size and shape, respectively) was performed
to assess their potential and translational value.
Several cell densities (2 × 106 cells/mL; 4 × 106 cells/mL; 8
× 106 cells/mL) have been tested (data not shown) to guarantee
a proper cell-cell contact within the hydrogel and, at the same
time, to avoid cellular overgrowth with the subsequent loss of
hydrogels spherical and regular conformation over time.
Interestingly, a relatively low cell density (2 × 106 cells/mL)
guaranteed regular hydrogel shape and size up to 1 week of
culture (Figure 1C). This is in agreement with other studies,
which reported that tumor models with low cell density are
more homogeneous and regular if compared with self-aggregated
tumor spheroids (45).
NB Cell-Laden Alginate Spheres Viability,
Proliferation, and Sensitivity to Imatinib
Mesylate
High cellular viability and proliferation rate are key aspects
in designing hydrogels as in vitro cancer models. After
24 h of culture, we tested NB cells viability by using the
Calcein-Acetyoxymethyl ester (Calcein AM) viability assay,
discriminating live and dead cells, as green or red fluorescent
cells respectively.
We observed, for both cell lines, a cell viability >95%,
suggesting that the methodological approach needed for cells
embedment within the alginate spheres is not harmful for NB
cells (Figure 2A).
Moreover, we compared up to one-week alginate spheres and
traditional 2D culture system for their capability of supporting
NB cell proliferation (Figure 2B). This analysis showed a similar
proliferation rate for NB cells expanded by the two different
methods, proving that alginate spheres allow an optimal diffusion
of nutrients and vital gases toward NB cells. Finally we compared
the sensitivity of 3D and 2D cultured NB cells to the cytotoxic
effect of imatinib mesylate (Figure 2C). This tyrosine kinase
inhibitor provided benefits in some NB patients (46) and in 2D
showed both on target and off target effects (47). As in 2D, the
viability of NB cell-laden alginate spheres was not significantly
affected by low drug concentrations. On the contrary, NB cell-
laden alginate spheres were significantly more resistant than 2D-
cultured tumor cells to the cytotoxic drug concentrations used.
This suggests that 3D model may be a more suitable and reliable
platform for testing drugs with respect to 2D standard cultures.
Constitutive and IFN-γ-Induced
Immunophenotype of NB Cell-Laden
Alginate Spheres
In order to support the concept that NB cell-laden alginate
spheres might represent a systematic and reproducible pre-
clinical tool to test innovative NK-based immunotherapeutic
approaches, we verified whether NB cells expanded within
alginate spheres expressed the repertoire of ligands previously
described in 2D culture systems (19, 25). Moreover, we also
analyzed the effect of IFN-γ, which in 2D has been shown
to modulate the expression of HLA-I and PD-Ls immune
checkpoint molecules (31). NB cell-laden alginate spheres
were stained with specific mAbs and imaging was performed
with a fluorescence microscope, as described in materials and
methods section.
HLA-I was undetectable in both NB cell lines. On the
contrary, they were positive for PVR, a ligand of DNAM-
1 activating receptor, whose expression is associated to
high susceptibility to NK-mediated killing (19) (Figure 3,
Figures S1, S2). HTLA-230 also expressed B7-H3, PD-L1, and
PD-L2, whereas these molecules were virtually undetectable in
SH-SY5Y cells (Figure 3).
Upon IFN-γ-treatment NB cell-laden alginate spheres de novo
expressed HLA-I molecules. Moreover, upregulation (HTLA-
230) or de novo expression (SH-SY5Y) of B7-H3, PD-L1, and PD-
L2 immune checkpoint ligands was detected. Interestingly, these
effects were accompanied by downregulation of PVR, which
virtually disappeared (Figure 3 and Figure S2).
Phenotypic and Functional Analysis of NB
Cells Recovered From Alginate Hydrogels
In order to evaluate whether our 3D model can allow recovering
NB cells suitable for phenotypic and functional studies, HTLA-
230 cells were gently extracted from alginate hydrogels (see
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FIGURE 1 | NB cell-laden hydrogel tumor model. (A) Picture, optical image of NB-loaded alginate spheres and AFM figures showing NB cells clusters within the
hydrogels. (B) Representative images of DAPI-stained NB cells nuclei within alginate spheres at different time points and histological sections stained with H&E after 7
days of culture. (C) Quantitative analysis of the morphological parameters of the NB cell-laden alginate spheres to monitor the temporal change in the hydrogel
dimension (mean ± SD) up to 1 week of culture.
materials and method). The constitutive expression of different
surface molecules was analyzed by immunofluorescence and flow
cytometry (Figure 4 and Figure S3A). With the exception of
PD-L1, the analysis confirmed the ligand repertoire detected
in NB cell-laden alginate sphere (Figure 3). Moreover, we
could analyze other molecules regulating NK cell activity or
associated with NB biology. We observed a consistent good
expression of nectin-2 (an additional ligand of DNAM-1)
(14), GD2 (a NB-associated antigen) (2) and of CXCR4 (48).
Other molecules including HLA-II (interacting with the LAG-
3 immune checkpoint receptor) and various NKG2D ligands
(MICA, ULBP1-4) were virtually undetectable.
We also tested the capability of recovered NB cells,
either untreated or treated with IFN-γ, to induce NK cells
degranulation (Figure S3B, right). The efficacy of IFN-γ
treatment was checked analyzing HLA-I expression (Figure S3B,
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FIGURE 2 | Cell viability, proliferation, and sensitivity to imatinib mesylate. (A) Cell viability represented by live/dead images of NB cell-laden alginate spheres after 24 h
of culture. (B) Quantitative analysis of the proliferation rate of NB cells embedded within alginate spheres assessed through Presto Blue assay. (C) Cell viability of
HTLA-230 cell-laden alginate spheres treated for 24 h with the indicated concentration of imatinib mesylate. Cell viability was derived as % of alive cells normalized
respect the untreated controls. Values are reported as mean+S.E. ∗P < 0.05.
left). Effectors were represented by NK cells from peripheral
blood of healthy donors, who have been selected considering
the HLA-I haplotype of HTLA-230 target cells. In particular,
two donors were chosen that presented a subset of educated
KIR/KIR-L mismatched NK cells, e.g., NK cells expressing
inhibitory receptors specific for a KIR-L present in the
donor and absent in target cells. Untreated (HLA-Ineg) NB
cells induced degranulation in both KIR/KIR-L mismatched
and matched NK cell subsets. On the contrary, IFN-γ
treated NB cells, that upon cytokine conditioning expressed
protective amounts of HLA-I molecules, induced degranulation
in KIR/KIR-L mismatched but not in KIR/KIR-L matched
NK cells.
Gene Expression Analysis of NB
Cell-Laden Alginate Spheres
To verify at what level occurred the IFN-γ regulation of the
immune checkpoint molecules and PVR ligand, 3D cultured
HTLA-230 and SH-SY5Y cell lines were recovered at day 7, and
analyzed by real-time PCR for the expression of the molecules of
interest. As shown in Figure 5, in both cell lines IFN-γ treatment
significantly increased the mRNA expression levels of B7-H3,
PD-L1, and PD-L2. This was paralleled by decreased mRNA
expression of PVR, which however was detectable in the HTLA-
230 cell line only.
These data confirmed the results obtained by immunostaining
of NB cell-laden alginate spheres and immunofluorescence
analysis, and suggested that the IFN-γ-mediated modulatory
effect occurred mainly at transcriptional level.
Constitutive and IFN-γ-Induced
Immunophenotype of NB Cultured in 2D
Systems
Immunofluorescence analysis of NB cell-laden alginate spheres
has been performed extending the cell cultures over a week,
whereas previous published analyses carried out in a traditional
2D culture system were performed at earlier time points (31).
Thus, in order to better compare NB cell-laden alginate spheres
with conventional 2D cultures, HTLA-230 and SH-SY5Y NB cell
lines have been cultured in 2D for 7 days, either in the absence or
in the presence of IFN-γ, and their immunophenotype analyzed
by immunofluorescence and flow cytometry.
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FIGURE 3 | INF-γ effect in NB cells cultured within 3D alginate spheres. Immunofluorescent images of PVR, B7-H3, PD-L1, PD-L2, and HLA-I expression (in red) in
NB cell-laden alginate spheres cultured a week either in the absence or in the presence of INF-γ. The anti-NKp46 mAb is used as a negative control.
As shown in Figure 6, the constitutive immunophenotype of
2D NB cells only partially overlapped with that of NB cell-laden
alginate spheres (see Figure 3). 2D NB cell were HLA-Ineg and
PVRpos, but presented a different repertoire or surface densities
of immune checkpoint molecules. In particular, both cell lines
expressed high levels of B7-H3, and among the PD-Ls only PD-L1
was detected, whose expression was restricted to SH-SY5Y.
Relevant differences also existed upon IFN-γ treatment. As
in 3D, IFN-γ increased the HLA-I and PD-L1 expression. On
the other hand, in 2D system, increments in surface expression
levels of B7-H3 and PD-L2 were only detected in 2D-cultured
HTLA-230 and SH-SY5Y, respectively (Figure 6). Notably, the
strong downregulation of PVR observed in IFN-γ-treated NB
cell-laden alginate spheres, was not observed in 2D NB cells even
after 7 days of culture.
DISCUSSION
In the last decades 2D cultures significantly contributed to
the identification and characterization of molecules involved
in anti-tumor immune responses. However, it is known that
culturing cancer cells in a 3D niche may better reproduce the
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FIGURE 4 | Constitutive surface phenotype of NB cells recovered from 3D alginate hydrogel. HTLA-230 cells recovered from alginate hydrogels were evaluated by
immunofluorescence and flow cytometry for the expression of the indicated molecules. Four independent experiments are shown. The Median Intensity Fluorescence
(MFI) is shown.
tumor architecture respect standard 2D cultures. 3D structures
often significantly increase malignant phenotypes of cancer cells,
which, instead, are suppressed in cells cultured in 2D conditions
(49). This can explain the lower sensitivity to chemotherapeutic
agents observed in 3D culture conditions as compared to 2D
systems (50, 51).
Here we developed a novel 3D alginate-based hydrogel
for culturing NB cells and evaluated the effects of the
three-dimensionality on different NB cell properties such as
morphology, cell viability, proliferation, sensitivity to drugs and
immunophenotype. The novelty of our model relies on the fact
that the few alternative 3D hydrogels proposed as NB models are
based on natural polymer like collagen and Matrigel (50, 52–54).
However, polymers of animal origin often show some limitations
as difficult reproducibility due to variations between the different
lots and the scarce possibility of modulating the biomechanical
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FIGURE 5 | Real-time PCR analysis of NB cells recovered from 3D alginate hydrogel. Expression of target genes is normalized to that of the GAPDH reference gene.
Data in triplicate are shown. Expression relative fold changes are referred to the gene expression in untreated cells, whose expression has been arbitrarily assigned the
value 1. Student’s t-test. ns, not significant; *P < 0.05; **P < 0.01, ***P < 0.001, ****P < 0.0001.
features of the final hydrogel. On the contrary, alginate properties
can be easily tuned for biofabrication specific needs in order to
obtain 3D chemically stable structures with optimal features.
In addition, the goal of the work was to develop a 3D
hydrogel to evaluate the effects of the three-dimensionality on
different NB cell features. Alginate is an inert polymer, differently
from collagen and protein based natural polymers, because
it lacks the native bonds that are usually responsible of the
interactions with mammalian cells. Therefore, the choice of this
polymer allowed to better decouple the contribution of the three-
dimensionality on cell fate from a possible chemical conditioning
due to the bioactivity of the substrate. However, most of the
current 3D models for neuroblastoma are based on growing
cells as spheroids starting from single cell suspensions (55–
58). Although they replicate specific features of in vivo tumors
including central hypoxic conditions, heterogeneity in phenotype
and gene expression and altered cellular metabolism, the tumor
spheroid model suffers from some limitations, particularly due
to a lack of surrounding extracellular matrix components. This
hampers the possibility to add other cell types, different from
tumor cells with the aim to reproduce the cellular complexity of
tumor microenvironment.
An additional novelty in our study is represented by the kind
of analysis that has been performed. Indeed for the first time to
our knowledge, we analyzed the expression in a 3D in vitro system
of a wide repertoire of surface ligands crucial in the regulation of
NK- and T- mediated immune responses against tumors.
As first result, we found that two prototypic NB cells (HTLA-
230 and SH-SY5Y) differing for the amplification status of the
prognostic factor MYCN (31), proliferated within our hydrogel
spheres with a rate comparable with traditional 2D cultures,
but with a spheroid morphology and a clustered organization,
resembling the in vivo phenotype (59), revealing the suitability
of the alginate-based model.
It is known from the literature that matrix stiffness plays
an important role in modulating in vitro tumors progression
(60, 61). For this reason, the polymer concentration was properly
set based on our previous work (42), which claimed that, among
hydrogels with different concentrations (0.5% w/V, 1%w/V,
2%w/V), the lowest concentrated alginate-based hydrogel was
the best in supporting breast cancer cell lines proliferation in
vitro. Hydrogels with a concentration lower than 0.5% w/V
did not possess a proper robustness and, therefore, couldn’t
guarantee a structural stability during the period of in vitro
cell culture.
Specifically, Marrella et al. reported that when cells are
cultured over artificial environments their preference toward
a substrate depends on the similarity of physical-mechanical
proprieties of the substrate with ones of the cell native tissue
(62). Therefore, soft substrates represent proper environments
where to grow cells derived from soft tissues, such as breast, or
nervous tissue.
These considerations are consistent with previous reports
(63), where the increasing of matrix stiffness of collagen-based
3D hydrogels led to a decreased proliferation of glioma cells.
In fact, brain tissue is one of the softest tissues in the human
body (64) and extensive in vitro studies have shown that neurons,
glia and neural stem/progenitor cell better respond when are
cultured over soft substrates (65–69). Thus, due to the similarities
between NB cells and the cells of embryonic neural crests from
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FIGURE 6 | Constitutive and IFN-γ-induced immunophenotype of NB cells cultured for 7 days in 2D systems. (A) Surface phenotype of NB cell lines cultured a week
either in the absence or in the presence of IFN-γ (immunofluorescence and flow cytometry). The anti-NKp46 mAb is used as a negative control. Four independent
experiments with mean, 95% confidence intervals, and significance are shown. *p < 0.05. (B) A representative experiment is shown. White profiles refer to cells
incubated with isotype-matched controls. Values inside each histogram indicate the MFI.
which NB derives, our culture system was based on a soft 3D
alginate-based model.
Besides supporting NB cells proliferation, this model appeared
to allow an optimal diffusion of nutrients and vital gases as
revealed by the high viability of NB cells encapsulated within
the hydrogels. Moreover, it preserves the proper physiology of
NB cells growing in tumor microenvironment in vivo as also
indicated by the higher drug resistance of NB cell-laden alginate
spheres as compared to 2D systems. The effective diffusion of
soluble molecules in our 3D alginate-based model was confirmed
by the effect in NB cell-laden alginate spheres of IFN-γ, a
crucial immunostimulatory cytokine released by activated NK
and T helper lymphocytes. IFN-γ promotes the activity of
different immune cell types including DC and macrophages that,
acquiring high levels of HLA-I and HLA-II molecules, optimize
antigen presentation to T lymphocytes. Importantly, immune
responses need to be modulated in their duration and amplitude
in order to achieve their resolution, avoiding the establishment
of autoimmune aggression. The mechanisms preventing such
detrimental events include the expression of immune checkpoint
ligands such as PD-L1 and PD-L2 (23) acquired by Antigen
Presenting Cells and by other cell types during the late phase
of the immune responses. Importantly, it has been shown in 2D
cultured systems that IFN-γ increased PD-Ls surface expression
not only in healthy cells but also in different tumors, including
NB (70), which become protected from the NK (and T)-mediated
attack. IFN-γ-conditioning also led to the de novo acquisition of
high levels of HLA-I, as demonstrated in NB cell lines and bone-
marrow NB metastasis (31). HLA-I expression may exert both
positive and negative effects, rendering NB cells more susceptible
to T cell-mediated recognition, but highly resistant to the NK-
mediated attack.
Our 3D culture system confirms data obtained in conventional
2D, including the IFN-γ-mediated expression inNB cells of HLA-
I and PD-Ls molecules. It is of note that phenotypic differences
have been appreciated in NB cells cultured in 2D system for 48 h
(31) or for a week (Figure 6). In particular, the IFN-γ-mediated
upregulation of B7-H3 in HTLA-230 cell line was appreciated
only in cells cultured for 7 days. Moreover, differently from
previous published results (31), low or null constitutive levels of
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PD-Ls and HLA-I were detected in 1 week cultured SH-SY5Y
cells. This immunophenotype is more similar to that observed in
SH-SY5Y cells xenografted in mice and removed after 3 weeks
of growth. This suggests that in 2D culture systems variables
may exist, including the number of cultured cells and cell-to
cell interactions, that could impact on the surface expression of
relevant molecules.
The 3D culture system also highlighted some unappreciated
NB biological features. Among these, IFN-γ mediated an
increment of the “NK-protective” ligands B7-H3 (25, 28, 71),
PD-Ls and HLA-I that was higher in MYCN amplified than
in non-amplified NB cells. This observation is particularly
relevant if considering that MYCN amplified NBs represent
the most aggressive subtype, often resistant to combined
therapies. Standard therapy for high-risk NB patients includes
an immunotherapy approach based on the use of antibodies
targeting the disialoganglioside GD2, a tumor-associated antigen
expressed by most NBs (72). In this context, NB cell-laden
alginate spheres maintain a high expression of GD2. The efficacy
of antibodies-mediated therapies relies on the triggering of
FcγRs+ cells such as NK cells and macrophages that altogether
release a great amount of IFN-γ, TNF-α, IL-1, and IL-6. Blood
accumulation of these cytokines unleash a Cytokine Release
syndrome (CRS), which represents a detrimental event also
associated to therapies utilizing Chimeric Antigen Receptors
(CAR)-engineered T and NK cells (73–75).
Notably, our 3D model showed that IFN-γ is also capable
of reducing the expression of PVR, a ligand of DNAM-1, an
activating receptor involved in NK-mediated recognition of
various tumors including NB (16–18, 76, 77). Importantly, bone
marrow metastasis lacking PVR expression have been detected
in NB patients, suggesting that loss of PVR might occur in
vivo, possibly potentiated by the pressure of immune system
(25). Thus, PVR expression in NB cell-laden alginate spheres
and its reduction upon IFN-γ-conditioning, phenomenon
unappreciated in 2D standard culture conditions, well resemble
the PVR variations occurring in vivo. This further suggests
that NB cell-laden alginate spheres might represent a more
appropriate culture system where to test immunotherapies. In
particular, recent therapeutic approaches aim to target PVR,
which is expressed by several tumor histotypes and by tumor-
associated endothelium (14, 70). Strategies include PVR targeting
using a modified attenuated poliovirus or T cell engineered with
DNAM-1 chimeric antigen receptor (78–80).
Thus, the here proposed 3D model based on NB cell-
laden alginate spheres appears to well preserve the physiology
and immunophenotype of NB cells and might represent a
reproducible and standardized tool to test different therapeutic
approaches allowing a more precise monitoring of tumor
responses as compared to animal preclinical models, often
allowing tumor analysis only at few critical time points.
Moreover, in our 3D model several test replicates can be
easily performed, ensuring a faster achievement of statistical
significance of the experiment with reduction of costs and animal
sacrifice in accordance with 3R European rules.
To conclude, 3D hydrogel cultures well resembled in vivo
NB cells growth due to their spheroid morphology and
highlighted a novel and clinical-relevant constitutive and IFN-
γ-inducible NB immunophenotype. Our data suggest that an
alginate-based in vitro culture model might be envisaged as
a future platform where to culture patients derived tumor
cells. This will be the next mandatory step of our 3D
culture system approach, crucial for set up and validate
personalized therapeutic approaches and for the evaluation of
their efficacy.
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